Trial Condition(s):

Erectile Dysfunction

LEVITRA® 20mg Special Drug Use Investigation (long-term)

Bayer Identifier:

13930

ClinicalTrials.gov Identifier:

NCT00909233

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.

Inclusion Criteria
:
 - This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
1221
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Japan

Status
Completed
 

Trial Design